tiprankstipranks
Lineage Cell Therapeutics, Inc. (DE:BT3)
FRANKFURT:BT3

Lineage Therap (BT3) Ownership - Who Owns Lineage Therap?

0 Followers

Lineage Therap (BT3) Ownership Overview

0.00%0.00%0.15%99.85%
0.15% Other Institutional Investors
99.85% Public Companies and
Individual Investors
The ownership structure of Lineage Therap (DE:BT3) stock is a mix of institutional, retail and individual investors. Approximately 0.15% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.85% is owned by Public Companies and Individual Investors.
The ownership structure of Lineage Therap (DE:BT3) stock is a mix of institutional, retail and individual investors. Approximately 0.15% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.85% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 08, 2024
Don Bailey
Director
Bought$100001
Feb 08, 2024
Broadwood Partners Lp
Director, >10% Owner
Bought$7000001
Jan 02, 2024Bought$10900

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$10900
Dec 31, 2023Bought$2323466
Dec 31, 2023Sold$5416945

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,888,942Insider6,613,384
83,420,138Insider80,083,332
631,554Insider606,292
1,109,290Insider1,064,918
34,093,007Insider32,729,287
97,450Insider93,552
893,913Insider858,156
64,100Insider61,536
10,000Insider9,600
87,500Insider84,000

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
900Institution930
42,175Institution43,567
1,581,471Institution1,633,660
39,978Institution41,297
60,723Institution62,727
-12,500Institution-12,913
56,595Institution58,463
1,410,750Institution1,457,305
767,100Institution792,414
67,474Institution69,701

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Lineage Cell Therapeutics, Inc. (DE:BT3)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 99.85% is held by retail investors.
    What percentage of Lineage Cell Therapeutics, Inc. (DE:BT3) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.15% of Lineage Cell Therapeutics, Inc. (DE:BT3) stock is held by institutional investors.
      What percentage of Lineage Cell Therapeutics, Inc. (DE:BT3) stock is held by retail investors?
      According to the latest TipRanks data, approximately 99.85% of Lineage Cell Therapeutics, Inc. (DE:BT3) stock is held by retail investors.
        Who owns the most shares of Lineage Cell Therapeutics, Inc. (DE:BT3)?
        Alfred Kingsley owns the most shares of Lineage Cell Therapeutics, Inc. (DE:BT3).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis